Serum levels of soluble IL-2 receptor, IL-12, IL-18, and IFN-γ in patients with acute graft-versus-host disease after allogeneic bone marrow transplantation

This publication has 14 references indexed in Scilit:

• Interleukin-18: A Novel Cytokine That Augments Both Innate and Acquired Immunity
  Published by Elsevier ,1998
• Characterization of anti-human interleukin-18 (IL-18)/interferon-γ-inducing factor (IGIF) monoclonal antibodies and their application in the measurement of human IL-18 by ELISA
  Journal of Immunological Methods, 1997
• CYTOKINE CASCADES IN ACUTE GRAFT-VERSUS-HOST DISEASE1
  Transplantation, 1997
• The Immunopathophysiology of Acute Graft‐Versus‐Host‐Disease
  The International Journal of Cell Cloning, 1996
• Dysregulation of Cytokines During Graft-Versus-Host Disease
  Journal of Hematotherapy, 1996
• The Molecular Cell Biology of Interferon-gamma and its Receptor
  Annual Review of Immunology, 1993
• ENDOGENOUS IFN-GAMMA DURING HUMAN BONE MARROW TRANSPLANTATION
  Transplantation, 1990
• Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells.
  Proceedings of the National Academy of Sciences, 1990
• Lymphokine gene expression in vivo is inhibited by cyclosporin A.
  The Journal of Experimental Medicine, 1990
• SOLUBLE INTERLEUKIN-2 RECEPTORS IN SERUM AND BILE OF LIVER TRANSPLANT RECIPIENTS
  The Lancet, 1989